bisoprolol has been researched along with Cardiac Diseases in 11 studies
Bisoprolol: A cardioselective beta-1 adrenergic blocker. It is effective in the management of HYPERTENSION and ANGINA PECTORIS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Bisoprolol reduces the perioperative incidence of death from cardiac causes and nonfatal myocardial infarction in high-risk patients who are undergoing major vascular surgery." | 9.09 | The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery. Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiography Study Group. ( Baars, HF; Bax, JJ; Blankensteijn, JD; Boersma, E; Poldermans, D; Roelandt, JR; Thomson, IR; Trocino, G; van de Ven, LL; van Urk, H; Vigna, C; Yo, TI, 1999) |
| "Bisoprolol significantly reduced long-term cardiac death and myocardial infarction in high-risk patients after successful major cardiac vascular surgery." | 9.09 | Bisoprolol reduces cardiac death and myocardial infarction in high-risk patients as long as 2 years after successful major vascular surgery. ( Baars, HF; Bax, JJ; Boersma, E; Paelinck, B; Poldermans, D; Roelandt, JR; Scheffer, MG; Thomson, IR; Trocino, G; van de Ven, LL; van Urk, H; Vigna, C, 2001) |
| "Bisoprolol reduces the perioperative incidence of death from cardiac causes and nonfatal myocardial infarction in high-risk patients who are undergoing major vascular surgery." | 5.09 | The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery. Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiography Study Group. ( Baars, HF; Bax, JJ; Blankensteijn, JD; Boersma, E; Poldermans, D; Roelandt, JR; Thomson, IR; Trocino, G; van de Ven, LL; van Urk, H; Vigna, C; Yo, TI, 1999) |
| "Bisoprolol significantly reduced long-term cardiac death and myocardial infarction in high-risk patients after successful major cardiac vascular surgery." | 5.09 | Bisoprolol reduces cardiac death and myocardial infarction in high-risk patients as long as 2 years after successful major vascular surgery. ( Baars, HF; Bax, JJ; Boersma, E; Paelinck, B; Poldermans, D; Roelandt, JR; Scheffer, MG; Thomson, IR; Trocino, G; van de Ven, LL; van Urk, H; Vigna, C, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (9.09) | 18.7374 |
| 1990's | 2 (18.18) | 18.2507 |
| 2000's | 6 (54.55) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (18.18) | 2.80 |
| Authors | Studies |
|---|---|
| Wongcharoen, W | 1 |
| Chotayaporn, T | 1 |
| Chutikhongchalermroj, K | 1 |
| Tantraworasin, A | 1 |
| Saeteng, S | 1 |
| Arworn, S | 1 |
| Rerkasem, K | 1 |
| Phrommintikul, A | 1 |
| Toda, H | 1 |
| Nakamura, K | 1 |
| Shimizu, K | 1 |
| Ejiri, K | 1 |
| Iwano, T | 1 |
| Miyoshi, T | 1 |
| Nakagawa, K | 1 |
| Yoshida, M | 1 |
| Watanabe, A | 1 |
| Nishii, N | 1 |
| Hikasa, Y | 1 |
| Hayashi, M | 1 |
| Morita, H | 1 |
| Morimatsu, H | 1 |
| Ito, H | 1 |
| Fleischmann, KE | 1 |
| Beckman, JA | 1 |
| Buller, CE | 1 |
| Calkins, H | 1 |
| Fleisher, LA | 1 |
| Freeman, WK | 1 |
| Froehlich, JB | 1 |
| Kasper, EK | 1 |
| Kersten, JR | 1 |
| Robb, JF | 1 |
| Valentine, RJ | 1 |
| Poldermans, D | 2 |
| Boersma, E | 2 |
| Bax, JJ | 2 |
| Thomson, IR | 2 |
| van de Ven, LL | 2 |
| Blankensteijn, JD | 1 |
| Baars, HF | 2 |
| Yo, TI | 1 |
| Trocino, G | 2 |
| Vigna, C | 2 |
| Roelandt, JR | 2 |
| van Urk, H | 2 |
| Lee, TH | 1 |
| Dickerson, LM | 1 |
| Carek, PJ | 1 |
| Litwack, RS | 1 |
| Gilligan, DM | 1 |
| DeGruttola, V | 1 |
| Lechat, P | 1 |
| Hulot, JS | 1 |
| Escolano, S | 1 |
| Mallet, A | 1 |
| Leizorovicz, A | 1 |
| Werhlen-Grandjean, M | 1 |
| Pochmalicki, G | 1 |
| Dargie, H | 1 |
| Prichard, BN | 1 |
| Robin, JM | 1 |
| Paelinck, B | 1 |
| Scheffer, MG | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Using Heart Rate Variability to Analyze the Effect of Beta Blockers on Intermediate Risk Patients Undergoing Laparoscopic Surgical Procedures[NCT01330654] | 0 participants (Actual) | Interventional | 2011-03-31 | Withdrawn (stopped due to no patients were enrolled. Study was closed prior to study start.) | |||
| Efficacy and Safety on Heart Rate Control With Ivabradine on Cardiogenic Shock (ES-FISH)[NCT03437369] | Phase 4 | 22 participants (Anticipated) | Interventional | 2018-05-31 | Not yet recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
5 trials available for bisoprolol and Cardiac Diseases
| Article | Year |
|---|---|
Effects of short-term bisoprolol on perioperative myocardial injury in patients undergoing non-cardiac surgery: a randomized control study.
Topics: Adrenergic beta-1 Receptor Antagonists; Bisoprolol; Double-Blind Method; Heart Diseases; Humans; Hyp | 2021 |
Effects of Bisoprolol Transdermal Patches for Prevention of Perioperative Myocardial Injury in High-Risk Patients Undergoing Non-Cardiac Surgery　- Multicenter Randomized Controlled Study.
Topics: Administration, Cutaneous; Adrenergic beta-1 Receptor Antagonists; Aged; Aged, 80 and over; Biomarke | 2020 |
The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery. Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiography Study Group.
Topics: Adrenergic beta-Antagonists; Aged; Bisoprolol; Female; Heart Diseases; Heart Rate; Humans; Incidence | 1999 |
Heart rate and cardiac rhythm relationships with bisoprolol benefit in chronic heart failure in CIBIS II Trial.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Bisoprolol; Blood Pressure; Chronic Dis | 2001 |
Bisoprolol reduces cardiac death and myocardial infarction in high-risk patients as long as 2 years after successful major vascular surgery.
Topics: Adrenergic beta-Antagonists; Aorta, Abdominal; Bisoprolol; Dobutamine; Echocardiography; Femoral Art | 2001 |
6 other studies available for bisoprolol and Cardiac Diseases
| Article | Year |
|---|---|
2009 ACCF/AHA focused update on perioperative beta blockade.
Topics: Adrenergic beta-Antagonists; Atrioventricular Block; Bisoprolol; Evidence-Based Medicine; Heart Dise | 2009 |
Reducing cardiac risk in noncardiac surgery.
Topics: Adrenergic beta-Antagonists; Bisoprolol; Heart Diseases; Humans; Incidence; Myocardial Infarction; M | 1999 |
Bisoprolol prevents mortality and myocardial infarction after vascular surgery.
Topics: Adrenergic beta-Antagonists; Aged; Bisoprolol; Female; Heart Diseases; Humans; Male; Multicenter Stu | 2000 |
Beta-blockade for patients undergoing vascular surgery.
Topics: Adrenergic beta-Antagonists; Bisoprolol; Exercise Tolerance; Heart Diseases; Humans; Myocardial Isch | 2000 |
Beta-blockade and surgery.
Topics: Adrenergic beta-Antagonists; Bisoprolol; Heart Diseases; Humans; Myocardial Infarction; Myocardial I | 2001 |
Optimization of beta-blockers for cardiovascular care. International Bisoprolol Symposium. Rabat, Morocco, November 20-22, 1985.
Topics: Adrenergic beta-Antagonists; Bisoprolol; Heart Diseases; Humans; Hypertension; Propanolamines | 1986 |